Pembrolizumab in the Treatment of Breast Cancer
- PMID: 35857664
- DOI: 10.1056/NEJMe2207532
Pembrolizumab in the Treatment of Breast Cancer
Comment on
-
Pembrolizumab plus Chemotherapy in Advanced Triple-Negative Breast Cancer.N Engl J Med. 2022 Jul 21;387(3):217-226. doi: 10.1056/NEJMoa2202809. N Engl J Med. 2022. PMID: 35857659 Clinical Trial.
Similar articles
-
Predicted Value of PD-L1 for Patients With Cervical Cancer Treated With Pembrolizumab.J Clin Oncol. 2024 May 1;42(13):1596. doi: 10.1200/JCO.23.02479. Epub 2024 Mar 7. J Clin Oncol. 2024. PMID: 38452320 No abstract available.
-
Pembrolizumab in Microsatellite-Instability-High Advanced Colorectal Cancer.N Engl J Med. 2020 Dec 3;383(23):2207-2218. doi: 10.1056/NEJMoa2017699. N Engl J Med. 2020. PMID: 33264544 Clinical Trial.
-
Onset of subacute cutaneous lupus erythematosus after the initiation of immune checkpoint inhibitor therapy of cancer.Lupus. 2021 Mar;30(3):531-533. doi: 10.1177/0961203320983448. Epub 2021 Jan 6. Lupus. 2021. PMID: 33407044 No abstract available.
-
Gastrointestinal: Severe gastritis with complete gastric mucosal sloughing.J Gastroenterol Hepatol. 2021 Oct;36(10):2639. doi: 10.1111/jgh.15427. Epub 2021 Feb 23. J Gastroenterol Hepatol. 2021. PMID: 33624341 Review. No abstract available.
-
Immune Checkpoint Inhibition for Unresectable Malignant Pleural Mesothelioma.Drugs. 2021 Jun;81(9):971-984. doi: 10.1007/s40265-021-01506-0. Epub 2021 Jun 9. Drugs. 2021. PMID: 34106454 Review.
Cited by
-
SAMHD1 expression is a surrogate marker of immune infiltration and determines prognosis after neoadjuvant chemotherapy in early breast cancer.Cell Oncol (Dordr). 2024 Feb;47(1):189-208. doi: 10.1007/s13402-023-00862-1. Epub 2023 Sep 4. Cell Oncol (Dordr). 2024. PMID: 37667113 Free PMC article.
-
Neutrophil-Camouflaged Stealth Liposomes for Photothermal-Induced Tumor Immunotherapy Through Intratumoral Bacterial Activation.Pharmaceutics. 2025 May 5;17(5):614. doi: 10.3390/pharmaceutics17050614. Pharmaceutics. 2025. PMID: 40430905 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical